Merck & Company Inc (MRK)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 117,106,000 117,532,000 112,630,000 105,849,000 106,675,000 106,727,000 104,469,000 107,796,000 109,160,000 107,081,000 107,095,000 106,668,000 105,694,000 93,494,000 90,688,000 90,847,000 91,588,000 89,800,000 90,615,000 84,913,000
Total stockholders’ equity US$ in thousands 46,313,000 44,502,000 43,582,000 40,364,000 37,581,000 41,246,000 38,693,000 46,834,000 45,991,000 44,458,000 43,243,000 40,883,000 38,184,000 35,794,000 33,294,000 26,945,000 25,317,000 29,186,000 27,642,000 26,205,000
Financial leverage ratio 2.53 2.64 2.58 2.62 2.84 2.59 2.70 2.30 2.37 2.41 2.48 2.61 2.77 2.61 2.72 3.37 3.62 3.08 3.28 3.24

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $117,106,000K ÷ $46,313,000K
= 2.53

The financial leverage ratio of Merck & Company Inc has shown fluctuations over the observed period from March 31, 2020, to December 31, 2024.

The financial leverage ratio measures the extent to which a company relies on debt to finance its operations. Generally, a higher leverage ratio indicates higher financial risk, as the company has more debt compared to equity.

Merck & Company Inc's financial leverage ratio ranged from 3.24 on March 31, 2020, to a low of 2.30 on March 31, 2023. The ratio peaked at 3.62 on December 31, 2020. The trend in the financial leverage ratio shows a decreasing pattern from the end of 2020 onwards, indicating a reduction in the proportion of debt in the company's capital structure compared to equity.

Overall, the declining trend in Merck & Company Inc's financial leverage ratio suggests that the company has been reducing its reliance on debt financing over the observed period, which may indicate improved financial stability and reduced financial risk.


See also:

Merck & Company Inc Financial Leverage (Quarterly Data)